Delivery Order SPE2DB22D2206-SPE2DB25FJW71
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,308.18 for 400 mg Benlysta vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the major pharmaceutical distributor for medical supplies supporting federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $15,777.72 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $10,518.48 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single procurement action under the company's broader pharmaceutical supply agreement with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $12,330.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector supplies, with a completion date of October 3, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $12,330.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical product, with a completion date of August 19, 2025. This non-set-aside contract was awarded competitively on July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $2,629.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with a completion date of June 24, 2025. This non-set-aside contract was competitively awarded on June 2, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a $10,518.48 delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $6,152.80 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml syringes under a firm fixed price contract. The award, issued on September 2, 2025, with a completion date of September 23, 2025, represents a non-set-aside competitive award to supply this immunosuppressive medication to support federal healthcare requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,550.40 to AmerisourceBergen Drug Corp, a for-profit organization, to provide 120 mg vials of the pharmaceutical product BENLYSTA. The delivery order has a completion date of February 26, 2024 and was awarded on February 2, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as the prime contractor for this contract, which is not...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 8, 2025, for the supply of Benlysta 400 mg vials under a firm fixed price contract valued at $3,944.43, with a completion date of September 29, 2025. The contract was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical and medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJW71Delivery Order
The Defense Logistics Agency awarded a $13,678.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of October 2, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for this specialized medication. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains extensive experience fulfilling pharmaceutical supply needs across the Department of Defense and other federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements for specialized pharmaceuticals across multiple therapeutic domains in support of the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 9/11/25 |